Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i> V600E Colorectal Cancer
Mehlika Hazar-Rethinam(Massachusetts General Hospital), Ryan B. Corcoran(Massachusetts General Hospital), Nicholas A. Jessop(Massachusetts General Hospital), Heather A. Shahzade(Harvard University), Aparna R. Parikh(Massachusetts General Hospital), Marianna Kleyman(Harvard University), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Theodore S. Hong(Massachusetts General Hospital), G. Celine Han(Broad Institute), Leanne G. Ahronian(Harvard University), A. John Iafrate(Massachusetts General Hospital), Janet E. Murphy(Harvard University), Emily E. Van Seventer(Massachusetts General Hospital), Catriona B. Hong(Harvard University), Jeffrey W. Clark(Massachusetts General Hospital), Joseph M. Gurski(Massachusetts General Hospital), Brandon Nadres(Massachusetts General Hospital), Lifeng Chen(Harvard University), David Liu(University of Louisville), Eunice L. Kwak(Harvard University), Dora Dias‐Santagata(Harvard University), Jill N. Allen(Harvard University), Jason E. Faris(Royal Marsden NHS Foundation Trust)
Cited by 73
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k